{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:27:46Z","timestamp":1790180866229,"version":"4.1.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamacardio.2019.4717","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T11:31:26Z","timestamp":1577359886000},"page":"318","source":"Crossref","is-referenced-by-count":59,"title":["Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure"],"prefix":"10.1001","volume":"5","author":[{"given":"Olujimi A.","family":"Ajijola","sequence":"first","affiliation":[{"name":"Neurocardiology Research Center of Excellence, Cardiac Arrhythmia Center, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal A.","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Gonzales","sequence":"additional","affiliation":[{"name":"Neurocardiology Research Center of Excellence, Cardiac Arrhythmia Center, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Gornbein","sequence":"additional","affiliation":[{"name":"Department of Biomathematics, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy, and Genetics, Burdon Sanderson Cardiac Centre, University of Oxford, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy, and Genetics, Burdon Sanderson Cardiac Centre, University of Oxford, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Paterson","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy, and Genetics, Burdon Sanderson Cardiac Centre, University of Oxford, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyanam","family":"Shivkumar","sequence":"additional","affiliation":[{"name":"Neurocardiology Research Center of Excellence, Cardiac Arrhythmia Center, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagmeet P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Herring","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, Department of Physiology, Anatomy, and Genetics, Burdon Sanderson Cardiac Centre, University of Oxford, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"hoi190083r1","article-title":"Clinical neurocardiology-defining the value of neuroscience-based cardiovascular therapeutics.","author":"Shivkumar","journal-title":"J Physiol"},{"issue":"6","key":"hoi190083r2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"hoi190083r3","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1113\/JP271869","article-title":"Translational neurocardiology: preclinical models and cardioneural integrative aspects.","volume":"594","author":"Ardell","year":"2016","journal-title":"J Physiol"},{"issue":"22","key":"hoi190083r4","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement From the American Heart Association.","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"},{"issue":"14","key":"hoi190083r5","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1113\/JP271840","article-title":"Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease.","volume":"594","author":"Habecker","year":"2016","journal-title":"J Physiol"},{"issue":"13","key":"hoi190083r6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"issue":"18","key":"hoi190083r7","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.79.18.5485","article-title":"Neuropeptide Y: complete amino acid sequence of the brain peptide.","volume":"79","author":"Tatemoto","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5858","key":"hoi190083r8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"issue":"1","key":"hoi190083r9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(02)01889-7","article-title":"Pharmacology of neuropeptide Y receptor antagonists: focus on cardiovascular functions.","volume":"447","author":"Malmstr\u00f6m","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"hoi190083r10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.yjmcc.2007.10.001","article-title":"Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.","volume":"44","author":"Herring","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"hoi190083r11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2004.11.001","article-title":"Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.","volume":"38","author":"Heredia","year":"2005","journal-title":"J Mol Cell Cardiol"},{"issue":"16","key":"hoi190083r12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/heartjnl-2012-303443","article-title":"Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.","volume":"99","author":"Cuculi","year":"2013","journal-title":"Heart"},{"issue":"2","key":"hoi190083r13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/24.2.102","article-title":"Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure.","volume":"24","author":"Hulting","year":"1990","journal-title":"Cardiovasc Res"},{"issue":"4","key":"hoi190083r14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/oxfordjournals.eurheartj.a060526","article-title":"Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction.","volume":"15","author":"Ullman","year":"1994","journal-title":"Eur Heart J"},{"issue":"3","key":"hoi190083r15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/hrt.71.3.261","article-title":"Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.","volume":"71","author":"Feng","year":"1994","journal-title":"Br Heart J"},{"issue":"1 Pt 1","key":"hoi190083r16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.29.1.137","article-title":"Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.","volume":"29","author":"Morris","year":"1997","journal-title":"Hypertension"},{"key":"hoi190083r17","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.ijo.0801915","article-title":"The NPY\/AgRP neuron and energy homeostasis.","volume":"25","author":"Morton","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"24","key":"hoi190083r18","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/eurheartj\/ehz115","article-title":"Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.","volume":"40","author":"Herring","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"hoi190083r19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/cs0830205","article-title":"Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.","volume":"83","author":"Mouri","year":"1992","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"hoi190083r20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0009-8981(90)90270-3","article-title":"Radioimmunoassay for plasma neuropeptide-Y in physiological and physiopathological states and response to sympathetic activation.","volume":"192","author":"Miller","year":"1990","journal-title":"Clin Chim Acta"},{"issue":"20","key":"hoi190083r21","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hoi190083r22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"issue":"18","key":"hoi190083r23","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9169","key":"hoi190083r24","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"hoi190083r25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.hrthm.2015.01.045","article-title":"Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: Neuropeptide and morphologic changes.","volume":"12","author":"Ajijola","year":"2015","journal-title":"Heart Rhythm"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2757539\/jamacardiology_ajijola_2019_oi_190083_1609877318.42696.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T01:21:07Z","timestamp":1610241667000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2757539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2019.4717","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}